BPC
EVH icon

Bryce Point Capital’s Evolent Health EVH Stock Holding History

Bryce Point Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,044
Closed -$687K – 197
2025
Q2 		$687K Sell
61,044
-33,417
-35% -$307K 0.58% 106
2025
Q1 		$883K Buy
+94,461
New +$954K 0.66% 56

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bryce Point Capital's EVH Position: Q3 2025 in Review

Bryce Point Capital sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 61,044 shares — an estimated $687K sold.

Bryce Point Capital first reported a position in EVH in Q1 2025 and held it in 2 quarters. The position peaked at $883K in Q1 2025. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Bryce Point Capital reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Bryce Point Capital sold 61,044 Evolent Health shares in Q3 2025, an estimated $687K.
  • Bryce Point Capital first reported a position in Evolent Health in Q1 2025 and held it in 2 quarters.
  • Bryce Point Capital's Evolent Health position peaked at $883K in Q1 2025.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.